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Abstract
Background: Itai-itai disease primarily results from cadmium (Cd) exposure and is known as one of the four major
pollution diseases in Japan. Cd pollution is more serious in several areas of China than in Japan. However, there is
still a lack of information regarding the threshold level of Cd exposure for the adverse health effects in the general
Chinese population. This study aims to evaluate the reference value of urinary Cd (UCd) for renal dysfunction in a
Chinese population as the benchmark dose lower confidence limit (BMDL) based on a large sample survey.
Methods: A total of 6103 participants who lived in five Cd polluted areas of China participated in this study. We
analyzed UCd levels as a biomarker of exposure and urinary β2-microglobulin (Uβ2-MG) levels as a renal tubular
effect biomarker. The BMD studies were performed using BMD software. The benchmark response (BMR) was
defined as a 10 % additional risk above the background.
Results: There was a positive correlation between the UCd levels and the prevalence of Uβ2-MG. The BMD of
UCd for Uβ2-MG was estimated for each province. The findings showed that the BMD levels were related to
the participants’ geographic region, which may be partially due to the large differences in Cd exposure level,
ethnic group, lifestyle and diet of the sample population in these study areas. The reference level of UCd for
the renal effects was further evaluated by combining the five sets of data from all 6103 subjects. The overall
BMDLs of UCd for Uβ2-MG with an excess risk of 10 % were 2.00 μg/g creatinine (μg/g cr) in males and
1.69 μg/g cr in females, which were significantly lower than the World Health Organization (WHO) threshold
level of 5 μg/g cr for Cd-related renal effects.
Conclusions: The selection of the sample population and geographic region affected the BMDL evaluation.
Based on the findings of this survey of a large sample population, the UCd BMDLs for Uβ2-MG in males with
BMRs at 10 % were 2.00 μg/g cr. The BMD was slightly lower in females, which indicated that females may
be relatively more sensitive to Cd exposure than males.
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Background
Cadmium (Cd) is a non-essential element in the hu-
man body, and long-term exposure to sufficiently
high Cd levels through food and water consumption,
skin contact and inhalation may cause adverse health
effects, such as renal dysfunction and osteoporosis
[1–4]. Cd and its compounds are considered to be
human carcinogens (primarily cancer resulting from
inhalation exposures) [5], and Cd exposure is associ-
ated with breast cancer development in females [2].
Cd and its compounds are released to all elements of
the environment due to a number of human activ-
ities, such as mining, smelting, industrial activities,
waste disposal, application of fertilizer and pesticides
and vehicle exhaust [6–8]. Cd pollution in soil, water
and air, as well as different foods, has been frequently
reported in China in recent years, which imposes in-
creasing health risks to the public [8, 9]. To protect
people from the adverse effects of Cd exposure, it is
important to evaluate the reference level, which is the
lowest concentration of urinary Cd (UCd) with a low
probability of Cd-induced adverse health effects.
The benchmark dose (BMD) represents an estimate of
the dose corresponding to a specified level of increased
response (the benchmark response, BMR). It has been
suggested that the no observed adverse effect level
(NOAEL) can be replaced with the lower 95 % confi-
dence limit of BMD [10, 11]. Compared with the
NOAEL, the BMD method is not constrained as one of
the experimental doses and makes better use of the
dose–response information. This method more appro-
priately reflects the sample size and is regarded as a bet-
ter approach than NOAEL to estimate the reference
point for a continuous outcome variable [12].
Previous studies have examined the reference level
for Cd-induced kidney effects using the BMD method
and have currently displayed relatively large variations
in critical UCd levels [13–22]. The Japanese popula-
tion data from previous studies suggested that the
benchmark dose lower confidence limit (BMDL) of
UCd for renal effects ranged from 2.5 μg/g cr to
10.3 μg/g cr in males and 1.4 μg/g cr to 11.4 μg/g cr
in females [13–16]. Another study reported that the
BMDLs of UCd were between 0.5 μg/g cr to 1.2 μg/g
cr in a Swedish population [17], whereas some other
researchers reported BMDLs ranging from 0.44 μg/g
cr to 12.18 μg/g cr in Chinese populations [18–21].
The BMDL values may have been significantly af-
fected by many factors, such as the sample popula-
tion and Cd exposure levels, thereby necessitating
further studies to identify the possible factors affect-
ing the BMD evaluation.
Itai-Itai disease primarily results from cadmium (Cd)
exposure and is known as one of the four major
pollution diseases of Japan. Considering that Cd pollu-
tion is more serious in certain areas of China than in
Japan, environmental epidemiological studies on Cd pol-
lution in China clearly warrant more attention. However,
there is still a lack of information on the reference level
of Cd exposure for the adverse health effects in the gen-
eral Chinese population. The limited studies on the
Chinese population used a much smaller sample size
than the sample sizes of the Japanese population re-
ported in other studies (374 to 790 participants vs. 1270
to 3103 participants) [14–17, 19–21].
In the present study, a large sample survey of 6103
participants from five Cd-polluted provinces in China
was performed to identify the reference level of UCd
for renal dysfunction, with urinary β2-microglobulin
(Uβ2-MG) serving as the renal effect biomarker. The
BMD values of UCd for renal dysfunction in the
population of each study province were evaluated in-
dividually to study the effect of gender and the sam-
ple population on the BMD. Furthermore, the overall
BMD of UCd for renal dysfunction in the Chinese
population was assessed by combining the five data
sets from all 6103 subjects.
Methods
Area and study population
Industrial operations, particularly smelting and mining, are
considered to be one of the most important sources of Cd
pollution. Considering that the differences in the Cd expos-
ure levels, lifestyle, and eating habits of the study popula-
tion may be related to Cd’s toxic effects, we included
population groups from different geographic regions
(Hubei in central China, Guangdong in southern China,
Gansu in northwest China, and Yunnan and Guizhou in
southwest China) with known industrial Cd pollution, ra-
ther than from a single region. The five regions included
one slightly exposed area (Hubei), and four moderately/
highly exposed areas (Guangdong, Yunnan, Gansu and
Guizhou). The Hubei province in central China had less in-
dustrial Cd contamination than other areas, with soil Cd
concentrations ranging from 0.8 mg/kg to 1.47 mg/kg [23].
Extensive smelting and mining contributed to serious Cd
pollution in the Guangdong, Yunnan, Gansu and Guizhou
provinces. Dabaoshan Mine, located in Shaoguan, in the
Guangdong province, is the largest polymetallic mine in
southern China. Many mineral slag and acid mine effluents
have been discharged into the local rivers from the begin-
ning of mining operations in the 1970s. Gejiu in the Yun-
nan province, which is a well-known “Tin-producing city”
in southwest China, has more than 400 nonferrous metal
processing companies. Baiyin in the Gansu province, which
is a well-known “Copper-producing city” in northwest
China, has mined and smelted nonferrous metals (e.g., Cu,
Pb and Zn) since the 1960s. In Hezhang in the Guizhou
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province in southwest China, an indigenous zinc-smelting
method, which resulted in severe heavy metal pollution, has
been used for more than a century [24, 25]. Mineral slag
and mining and smelting wastewater have caused serious
pollution of the soil and local rivers (e.g., the Kafangdagou
River in Gejiu, Yunan province, the Dongdagou River in
Baiyin, Gansu province and the Magu River in Hezhang,
Guizhou province). Although low soil Cd contamination
was also observed in some unpolluted regions in
these provinces, the average soil Cd concentrations in
some polluted areas were as high as 5.7 mg/kg to
10 mg/kg [7, 9, 24]. The Cd contamination of rice in
the study areas described above has been monitored,
and more than 18 % of those samples had Cd con-
centrations greater than 0.2 mg/kg, which is the
current Chinese maximum allowable concentration
(MAC) of Cd in rice (detailed information will be re-
ported in another study).
Our study population included inhabitants of these
five Cd polluted areas. Approximately 12,000 subjects
were randomly selected from the towns and/or villages
in these areas based on the information from local resi-
dents. They were invited to participate in this study by
phone or by post. Individuals who responded positively
(approximately 80 % of 12,000 subjects) were then asked
to fill out a brief questionnaire. Subjects who had been
diagnosed with kidney and/or liver disease were ex-
cluded from the study. Participants who were occupa-
tionally exposed to heavy metals were also excluded.
The eligible subjects were asked to provide urine sam-
ples for biological measurements. A total of 6103 partici-
pants (51 % of 12,000 subjects), including 1496 (Gansu),
1565 (Hubei), 1239 (Guizhou), 736 (Guangdong), and
1067 (Yunnan), completed the questionnaires and
provided urine samples. Of those who provided urine
samples, 44 % (2715) were males and 56 % (3388) were
females, age 35 and older. Women were slightly more
likely than men to participate in this study and provide a
urine sample. All eligible subjects drank water from the
area at least once a week. Their primary occupation was
farming. Table 1 presents the data on the number
and ages of all participants from each province.
Ethical permission was obtained from the Ethics
Committee at Beijing Jiaotong University. Informed
consent was obtained from all participants.
Sampling and chemical analysis
Morning urine samples were collected from the eli-
gible participants. Each sample was divided into sev-
eral parts immediately after collection to measure the
UCd, Uβ2-MG and urinary creatinine (cr) concentra-
tions. UCd was determined using the standard
method described in previous studies [19, 26]. In
brief, the urine samples were collected in acid-washed
plastic containers and frozen at −20 °C until further
analysis. The urine samples were acidified with con-
centrated nitric acid, and the Cd concentrations in
the urine samples were then determined by graphite-
furnace atomic absorption spectrometry with peak
area evaluation. The linearity range of the calibration
curve (R2 = 0.996 to 0.999) was from 0 to 20 μg/L.
The method was validated by evaluating the quality
control sample and recovery. Two concentrations of
the quality control samples (5.1 μg/L and 15.0 μg/L)
were analyzed, which produced Cd concentrations of
4.9 ± 0.2 μg/L and 14.6 ± 0.4 μg/L. The relative stand-
ard deviations for Cd were 4.5 % and 2.7 % in the
two quality control samples, respectively. The average
Table 1 Characteristics of the population used in the study






UCd > 5 (%)a Uβ2-MG >
1000 (%)a
UCd > 5 &
Uβ2-MG >
1000 (%)a
Gansu Male 663 59.23 (35–87) 4.44 ± 2.47 (0.10 ~ 36.79) 660.87 (5.01–2911.50) 47.7 29.6 21.9
Hubei 724 60.45 (35–89) 4.69 ± 1.97 (0.21 ~ 33.32) 724.27 (2.42–5087.62) 46.4 38.8 23.8
Guizhou 548 59.26 (36–89) 6.60 ± 2.18 (0.08 ~ 56.99) 310.25 (6.50–4603.32) 67.7 19.5 17.0
Guangdong 321 62.39 (35–89) 4.06 ± 1.93 (0.81 ~ 24.86) 435.90 (0.76–2554.98) 33.6 29.3 11.8
Yunnan 459 61.13 (35–89) 4.37 ± 2.08 (0.56 ~ 31.96) 793.84 (4.91–5272.68) 36.4 42.7 20.5
Gansu Female 833 60.42 (35–89) 4.34 ± 2.64 (0.11 ~ 48.47) 654.79 (14.92–3320.68) 47.8 28.8 20.2
Hubei 841 60.72 (35–89) 4.84 ± 2.02 (0.17 ~ 42.05) 727.56 (5.59–4527.47) 49.9 40.3 27.5
Guizhou 691 58.53 (35–89) 6.50 ± 2.26 (0.05 ~ 57.27) 348.03 (3.46–5926.02) 67.9 30.7 25.6
Guangdong 415 61.17 (35–89) 3.94 ± 2.12 (0.13 ~ 45.62) 474.92 (1.55–3216.06) 36.6 31.6 18.3
Yunnan 608 56.38(35–88) 4.76 ± 2.25 (0.07 ~ 47.90) 745.64 (14.97–5645.35) 44.6 41.3 24.8
All regions Male 2715 60.26 (35–89) 4.82 (0.08–56.99) 570.86 (0.76–5272.68) 47.8 32.2 20.0
Female 3388 59.48 (35–89) 4.87 (0.05–57.27) 581.46 (1.55–5926.02) 50.5 34.6 23.7
Notes: GM geometric mean.aThe cut-off values for UCd and Uβ2-MG are expressed as μg/g cr
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recovery of adding different amounts of Cd for ana-
lyzing UCd was between 97.8 % and 103.0 %. The
UCd limit of detection was 0.07 μg/L. For analytical
quality assurance, one run of both the quality control
samples and the calibration standards were used for
every analytical run. Urinary β2-MG (Uβ2-MG) levels
were measured by radio-immunoassay (RIA) (Pharmacia
β2-micro RIA, Pharmacia Diagnostics AB, Sweden). Urin-
ary creatinine (cr) levels were measured as previously de-
scribed [19, 27]. All urinary parameters were adjusted for
the creatinine concentration and expressed as μg/g cre-
atinine (μg/g cr) [28].
Statistical analysis
SPSS 17.0 for Windows (SPSS Inc., Chicago, IL, USA)
and Origin 8.0 were used to conduct the statistical ana-
lyses. The variables were log-transformed to meet the
normal distribution requirements. The age, UCd and
Uβ2-MG means were calculated. The prevalence of the
elevated UCd and Uβ2-MG levels was calculated, and
the cut-off values were chosen according to available risk
assessment–based biomarker screening values. The
threshold values for UCd and Uβ2-MG used in this
study are 5 μg/g cr [29] and 1000 μg/g cr [30, 31], re-
spectively. One-way ANOVA was used to test for univar-
iate differences between groups. The results were
considered statistically significant at p <0.05 or 0.01
based on a two-tailed test. The data were expressed as
the mean or geometric mean (GM).
Benchmark dose (BMD) method
BMD studies were performed using BMDS (Version
2.3.1, Environmental Protection Agency, USA, http://
www.epa.gov/ncea/bmds/dwnldu.html). The subjects
were divided into four groups (UCd: 0–2, 2–6, 6–12
and >12 μg/g cr). On one hand, these subgroups were
selected based on previous studies [13, 14, 18, 19]
and the range and distribution of Cd exposure levels
of the sample population in this study. On the other
hand, having studies with one or more doses near the
BMR level is desirable to give a better estimate of the
BMD based on the Benchmark Dose Technical Guid-
ance. The Uβ2-MG level of 1000 μg/g cr was used as
the cut-off value [30, 31]. Based on the Benchmark
Dose Technical Guidance, most fitting methods will
provide a global goodness-of-fit measure, usually a
p-value. These measures quantify the degree to which
the dose-group means that are predicted by the
model differ from the actual dose-group mean, rela-
tive to the amount of expected variation in the dose-
group means. Small p-values indicate that the
goodness-of-fit statistical value at least this extreme is
unlikely to have been achieved if the data were actu-
ally sampled from the model, and, consequently, the
model is a poor fit to the data. When the p values
were higher than 0.05, the results of model fit were
considered to be satisfactory [19]. In a preliminary
study of this work, we tested different models, including
the Gamma, Logistic, Log-Logistic, Log-Probit and others.
Some of them have p < 0.05 for several study areas, and
these were ruled out for further consideration. Among the
remaining models, both the Gamma model and Log-
logistic model fit the data well, and they had similar low
Akaike’s Information Criterion (AIC) values (Based on the
Benchmark Dose Technical Guidance, the models with low
AIC values are preferred). Therefore, in most cases, the
BMDs and BMDLs for Cd-induced renal dysfunction were
calculated using a Gamma model based on the populations
from the five provinces. When the equation was not a
good fit, a Log-logistic model was chosen, as specified
in the text. The BMR was defined as a 10 % add-
itional risk above the background. The criterion sig-
nificance level was set at p < 0.05.
Results
Internal Cd exposure and the prevalence of renal
dysfunction in the subjects
A total of 6103 participants (2715 males and 3388 females)
from five Chinese provinces were included in this survey.
The subjects’ characteristics are shown in Table 1. The
number of subjects in each province varied from 321 to
724 for males and 415 to 841 for females. These subjects
were 35 years old or older, with the average ages ranging
from 56.4 to 62.4. A wide range of UCd concentrations was
observed (Table 1). The mean Cd levels of the subjects
from the Guangdong province were statistically lower
than the levels of the subjects from the other prov-
inces (p < 0.05). The highest UCd level of 6.50-
6.60 μg/g cr was recorded in the subjects from the
Guizhou province. The threshold value of 5 μg/g cr that
was set by the World Health Organization (WHO) [29]
was used as the cut-off value to calculate the prevalence
of the elevated UCd levels. Table 1 shows 67.7 % of males
and 67.9 % of females of the sample population from the
Guizhou province had measured UCd concentrations
greater than the threshold value of 5 μg/g cr, as opposed
to 33.6 %-49.9 % observed in the sample population from
the other four study areas.
The mean Uβ2-MG levels of the subjects from the
Guizhou and Guangdong provinces were statistically
lower (p < 0.05), whereas the highest levels of 793.84 μg/
g cr and 745.64 μg/g cr were observed in males and fe-
males, respectively, from the Yunnan province (Table 1).
For all subjects of the five provinces, the mean Uβ2-MG
levels were 570.86 μg/g cr in males and 581.46 μg/g cr
in females. A Uβ2-MG reference point of 1000 μg/g cr
for renal dysfunction was suggested by the Minister of
Health of the People's Republic of China (MOHC) in
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1998 [31]. It should be noted that the Uβ2-MG levels of
some subjects significantly exceeded the safety limit, in-
dicated by the 95th percentiles of the Uβ2-MG concen-
trations (1664.5-2689.8 μg/g cr, data not shown in the
Tables). However, the mean Uβ2-MG levels of the sub-
jects were statistically lower than the standard of
1000 μg/g cr (Table 1). The threshold value of 1000 μg/g
cr was used as the cut-off value to calculate the preva-
lence of the elevated Uβ2-MG levels, and the results are
shown in Table 1. In the sample population in the
Guizhou province, 19.5 % of males and 30.7 % of fe-
males had measured UCd concentrations greater than
the threshold value, whereas this value was exceeded
in 29.3 %-42.7 % of males and 28.8 %-41.3 % of fe-
males in the sample populations in the other four
study areas. Notably, both the UCd and Uβ2-MG
levels exceeded the corresponding threshold levels in
only 11.8 % of males and 18.3 % of females in the
Guangdong province compared to 17.0 %–23.8 % of
males and 20.2 %–27.5 % of females from the other
study areas.
The subjects from each province were divided into
four groups (UCd: 0 to 2, 2 to 6, 6 to 12 and >12 μg/g
cr), and the frequency that exceeded the Uβ2-MG stand-
ard were then calculated accordingly. The results are
shown in Table 2. The frequency that exceeded the Uβ2-
MG standard ranged from 8.3 % to 36.4 % and from
12.8 % to 47.8 % for the male subjects from the Guizhou
and Guangdong provinces, respectively. Compared to
these subjects, a relatively higher frequency exceeded the
Uβ2-MG standard was observed in the subjects from the
other regions. For all subjects from the five provinces,
the frequency exceeding the Uβ2-MG standard was
14.6 %–58.7 % in males and 14.5 %–65.4 % in females. It
is clear that the frequency that exceeded the threshold
level of Uβ2-MG increased with increasing UCd levels.
The frequency that exceeded the threshold level of Uβ2-
MG was within 14.6 % in all subjects when the UCd
levels ranged from 0 μg/g cr to 2 μg/g cr. When the
UCd levels were above 2 μg/g cr, a higher frequency was
recorded (26.3–65.4 %). The Chi-squared linear trend
test (p < 0.05) further verified that the prevalence of
renal dysfunction was correlated with increased UCd
levels. A dose–response relationship was apparent be-
tween the UCd levels and the prevalence of renal dys-
function, which is consistent with the findings of a
previous study [18].
The BMD of UCd for the renal dysfunction index in the
population from each province
Next, the BMDL of UCd for Uβ2-MG was calculated for
the population from each province using the BMD soft-
ware from the Environmental Protection Agency (Ver-
sion 2.3.1). The results for males are shown in Table 3.
All p values were higher than 0.05, which indicates that
the results of the model fit were satisfactory [19]. Using
the Uβ2-MG as an indicator of renal dysfunction, the es-
timated BMDL values of UCd were between 1.10 μg/g cr
and 2.11 μg/g cr in males from all provinces except the
Guizhou province. At a BMR of 10 %, the BMDL of
UCd in males from the Guizhou province reached




Gansu Hubei Guizhou Guangdong Yunnan All regions
+ - % + - % + - % + - % + - % + - %
0-2 9 97 8.5 13 53 19.7 3 33 8.3 5 34 12.8 13 35 27.1 43 252 14.6
2-6 51 241 17.5 117 275 29.8 22 168 11.6 57 136 29.5 113 191 37.2 360 1011 26.3
6-12 83 112 42.6 127 104 55.0 43 172 20.0 21 45 31.8 29 27 51.8 303 460 39.7
12- 53 17 75.7 24 11 68.6 39 68 36.4 11 12 47.8 41 10 80.4 168 118 58.7
χ2 120.490 24.990 18.052 3.967 13.592 173.238




Gansu Hubei Guizhou Guangdong Yunnan All regions
+ - % + - % + - % + - % + - % + - %
0-2 20 140 12.5 10 68 12.8 0 41 0.0 13 55 19.1 17 49 25.8 60 353 14.5
2-6 66 280 19.1 135 301 31.0 52 200 20.6 50 173 22.4 115 231 33.2 418 1185 36.1
6-12 98 136 42.1 157 121 56.5 81 181 30.9 47 50 48.5 63 58 52.1 446 545 45.0
12- 56 38 59.6 37 12 75.5 79 57 58.1 21 6 77.8 56 19 74.7 249 132 65.4
χ2 93.391 94.632 72.993 44.668 53.056 324.985
p 2.2e-16 2.2e-16 2.2e-16 2.2e-11 3.1e-13 2.2e-16
Notes: Chi-squared linear trend test, p < 0.05
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3.66 μg/g cr, which was appreciably higher than that of
the males from the other provinces.
The results for females are presented in Table 3. At a
BMR of 10 %, the BMDLs of UCd for Uβ2-MG were 1.59,
1.00, 1.94, 1.37, and 1.33 μg/g cr in females from Gansu,
Hubei, Guizhou, Guangdong and Yunnan, respectively.
The BMDL of UCd for Uβ2-MG in females from Guizhou
was obviously higher than that of the other areas. The
BMDLs of UCd for Uβ2-MG were lower in females than
in males, with the exception of Yunnan.
The BMD of UCd for the renal dysfunction index in the
total population of all five provinces
Despite the fact that the mean UCd and Uβ2-MG levels
among the subjects of some study areas were different,
an obvious dose–response relationship existed between
the UCd and the prevalence of renal dysfunction in both
the study population of single area and the total study
population of all five areas. Based on the Benchmark
Dose Technical Guidance, datasets that are statistically
and biologically compatible may be combined, resulting
in increased statistical and biological confidence in the
calculated BMD. Therefore, the overall BMD of UCd for
Uβ2-MG in the total population was then estimated by
combining the five data sets from all 6103 participants.
As shown in Table 3, the overall BMDLs of UCd for
Uβ2-MG with BMRs at 10 % were 2.00 μg/g cr in males
and 1.69 μg/g cr in females. The BMDLs in the total
population of females were slightly lower than those in
males (Table 3).
Discussion
The BMD of UCd for renal dysfunction in the popula-
tion of five different Chinese provinces was assessed in-
dividually using Uβ2-MG as the effect indicator, and the
results showed that the estimated BMD value was sig-
nificantly affected by the participants’ geographic region
and gender. For the first time, the BMD of UCd for kid-
ney dysfunction in the Chinese population was further
evaluated by combining the five data sets from all 6103
subjects. The overall BMDLs of UCd for Uβ2-MG with
an excess risk of 10 % was 2.00 μg/g cr in males and
1.69 μg/g cr in females of the total sample population.
These values were markedly lower than the reference
level of 5 μg/g cr for Cd-related kidney effects recom-
mended by the World Health Organization (WHO) [29].
Reports on individuals living in Cd-polluted and
non-Cd-polluted areas have shown a close relation-
ship between UCd excretion and the total body bur-
den of Cd or lifetime Cd intake [13]. Therefore, UCd
is considered to be a useful indicator of the internal
dose of Cd exposure. Uβ2-MG was chosen as an indi-
cator for Cd-induced renal effects [13, 14, 18]. The
Uβ2-MG level of 1000 μg/g cr, which is from GB/T
17221–1998 in China, was used as the cut-off value.
The threshold level for Uβ2-MG that is associated
with the conversion from reversible to irreversible
renal damage was determined to be 1000 μg/g cr of
Uβ2-MG excretion [32]. Kobayshi et al. employed
84 % and 95 % of the upper limit values of Uβ2-MG
of the non-smoking population as the cut-off values
[11]. Usually, the 95 % upper limit values, which were
994 μg/g cr for men and 784 μg/g cr for women in
their study, were used. When 95 % of the upper limit
value or 1000 μg/g cr were used as a cut-off value,
the value was the level over which the renal damage
may be irreversible [13].
It is difficult to arrive at a conclusion on the relationship
between the mean UCd and Uβ2-MG levels and the corre-
sponding prevalence of the elevated UCd and Uβ2-MG
Table 3 The BMDL estimates of the UCd for Uβ2-MG in the different regions and all regions
Area Sex AIC Chi-squared p-value BMD10 (μg/g cr) BMDL10 (μg/g cr)
Gansu Male 682.0 0.23 0.63 3.32 2.11
Hubei 914.0 3.21 0.07 2.01 1.13
Guizhou 518.5 0.13 0.72 6.56 3.66
Guangdong 386.2 3.4 0.18 3.66 2.02
Yunnan 591.3 0.04 0.98 2.33 1.10
All areas 3241.6 0.96 0.62 2.28 2.00
Gansu Female 911.1 3.41 0.06 2.95 1.59*
Hubei 1042.6 4.28 0.12 1.16 1.00
Guizhou 774.6 3.58 0.17 2.25 1.94
Guangdong 474.8 2.15 0.14 3.20 1.37
Yunnan 774.8 1.08 0.30 2.23 1.33
All areas 4046.0 4.33 0.12 1.87 1.69
Notes: Confidence Level: 95 %, BMR: 10 %. aThe BMDL value was calculated based on the Log-Logistic model. The BMD10 (BMDL10) is the BMD (BMDL)
corresponding to a 10 % additional risk
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levels by geographic regions. In some study areas, e.g.,
Hubei and Guangdong, the high UCd levels in the sample
population corresponded well with the high Uβ2-MG
levels as well as the high prevalence of the elevated UCd
and Uβ2-MG levels (Table 1). Notably, the results ob-
served in some other areas are different. The UCd level
and the corresponding prevalence of elevated UCd levels
in the subjects from Guizhou, which had more serious en-
vironmental [7] and food (e.g., rice) Cd pollution (detailed
information will be reported in another study), were sig-
nificantly higher than that observed in the other study
areas (Table 1). However, the Uβ2-MG levels of the sub-
jects in the Guizhou province were the lowest, despite
their high Cd exposure levels. The corresponding preva-
lence of the elevated Uβ2-MG levels was also lower than
that observed in most other study areas. Previous studies
also showed that the Uβ2-MG levels of a sample popula-
tion in a slightly exposed area were even higher than that
observed in another highly exposed area (699 vs. 507 μg/g
cr), whereas the UCd levels of the subjects in the former
were significantly lower (1.4 vs. 7.9 μg/g cr) [33]. These re-
sults may be due to large differences of the ethnic group
and lifestyle of the study population from different geo-
graphic regions. Even so, the Chi-squared linear trend test
(p < 0.05) demonstrated the positive correlation between
the prevalence of renal dysfunction and the UCd levels in
the sample population from each geographic region. A
positive correlation has also been reported in some
previous studies of the Chinese and Japanese popula-
tions [34, 35], which indicates that Uβ2-MG may be
an ideal biomarker for Cd-induced renal effects.
Thus far, the critical UCd levels for kidney effects have
displayed large variations. A study based on the Swedish
population showed that the BMDLs of UCd related to
renal dysfunction ranged from 0.5 μg/g cr to 1.2 μg/g cr
[17]. The BMDLs observed in Japanese samples varied
from 1.4 μg/g cr to 11.4 μg/g cr [13–16]. The BMDLs of
2.13–4.85 μg/g cr were obtained based on two sets of data
from occupational epidemiology in China [19]. The
BMDLs of UCd for the renal effects were between
0.44 μg/g cr and 2.62 μg/g cr in another Chinese popula-
tion from Cd-exposed areas [21]. These findings show that
the BMDLs for the Cd-induced adverse health effects may
be affected by many factors, such as race, effect bio-
markers, sampling differences and BMD analysis methods.
In the current study, the higher BMDLs of UCd for Uβ2-
MG were observed in both males and females from the
Guizhou province compared to the other provinces
(Table 3). The selection of the sample populations affected
the final BMDL values when a similar number of subjects
from each province and the same race, effect biomarker,
sampling and analytical procedures and BMD methods
were considered. The present results showed that the geo-
graphic region selection significantly affected the BMDL
evaluation. Because there was little difference between the
prevalence of Uβ2-MG in the males and females of the
Hubei (38.8 %–40.3 %) and Guangdong (40.3 %–41.3 %)
provinces, the BMD values were quite similar (1.00 to
1.13 μg/g cr vs. 1.10 to 1.33 μg/g cr). The frequency that
exceeded the standard of Uβ2-MG in the sample popula-
tions of Gansu, Guizhou and Guangdong ranged from
19.5 % to 31.6 %, which were significantly lower than
38.8 % to 42.7 % in the other two provinces (Table 1). The
corresponding BMDLs were higher than those observed
in the Hubei and Guangdong (1.37 to 3.66 μg/g cr vs. 1.00
to 1.33 μg/g cr). Previous studies reported that the preva-
lence of Uβ2-MG in females from Cd-polluted areas [13]
and non-polluted areas [30] was 30.4 % and 12.9 %, re-
spectively, and the corresponding BMD values of UCd
were also quite different (1.5 μg/g cr vs. 3.3 μg/g cr)
[13, 30]. Notably, the slightly exposed region (Hubei)
showed the lowest BMDs for both males and females,
whereas the highest values were observed in Guizhou.
These results may be partially due to significantly
higher Cd-exposure levels in Guizhou. Subjects who
are living in highly polluted areas may become some-
what more resistant to Cd toxicity than those in slightly
polluted areas. In addition, large differences of the ethnic
groups as well as different lifestyles may also affect Cd’s
toxic effect. More than 30 % individuals of the total popu-
lation in Guizhou belong to minority ethnic groups, while
this value in Hubei is only approximately 4 % (i.e., most of
local residents in Hubei are the Chinese Han nationality).
In addition, the BMDLs of UCd for renal dysfunction
were related to gender in addition to the sample popula-
tion. Previous findings on the effects of gender on BMD
values were different. In some studies, the BMDLs for
Cd-induced renal dysfunction in females were higher
than those in males [13, 16, 36]. However, other studies
reported that the BMDLs were lower in females [14, 15],
which indicated that the female subjects appear to be
somewhat more sensitive to Cd damage than the male
subjects. In the present study, the BMDLs of UCd for
Uβ2-MG in females were lower than those of the males
from each province, with the exception of the Yunnan
province (Table 3 and 4). The overall BMDLs of the total
population from all five provinces were also slightly
lower in females (Table 3). Therefore, these results pro-
vide additional support to the latter findings.
The data obtained from all 6103 subjects from the five
study areas were used to evaluate the reference level of
Cd-induced kidney effects. This was performed to increase
the statistical and biological confidence in the calculated
BMD. The present investigation on the BMD has a greater
statistical power than many previous studies of this type,
particularly those for Chinese populations. The number of
subjects in the present study was as high as 6103, much
larger than the number (N = 374–790) of Chinese subjects
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in previous studies [18–21]. The sample size was also rela-
tively larger than the Japanese populations in the previous
studies of Kobayashi et al. (N = 2778) [13], Suwazono et al.
(N = 1270) [15] and Suwazono et al. (N = 3103) [16]. Al-
though the number of subjects in a previous BMD study
of the Japanese population reached 6032 [36], these sub-
jects came from different surveys that were completed
separately in 1982 and 1998–2000 [34, 36]. In the present
study, all participants were in the same survey and the
same time frame. Furthermore, the exposure range
was relatively broader than that of the previous stud-
ies [13, 30]. As reported in a previous study based on
the population in non-polluted areas, the frequency
of subjects with UCd concentrations above 7 μg/g cr
was approximately 8 % [13]. The frequency in an-
other study based on the population in polluted areas
was 19 % [30]. In the current study, the frequency of
subjects with UCd concentrations above 6 μg/g cr
reached 40 %, based on the survey in the polluted
provinces, which indicated much broader Cd-exposure
levels in these subjects. In the present study, the estimated
BMDL of UCd for Uβ2-MG with BMRs set at 10 % was
2.00 μg/g cr in males and 1.69 μg/g cr in females. The
BMDLs obtained in the present study were significantly
lower than other reports on the BMDLs of 3.99–12.18 μg/
g cr in the Chinese population [18] and 2.4–11.4 μg/g cr
in the Japanese population [13, 16, 32]. The present re-
sults were similar to those obtained in Swedish fe-
males (0.5–1.2 μg/g cr) [17], the Japanese population
(1.4–2.6 μg/g cr) [15], the Chinese population that was
also exposed to arsenic (0.9–1.2 μg/g cr) (Hong et al., [37]),
and another Chinese population (0.44–0.53 μg/g cr) [21].
Previous studies have reported that the mortality risk
significantly increases among the subjects with UCd
values higher than 3 μg/g cr after age adjustment [38].
Cd toxicity has already been evaluated by several inter-
national bodies, including the International Agency for
Research on Cancer, the Joint Food and Agriculture
Organization (FAO)/WHO Expert Committee on Food
Additives (JECFA) (2003, 2006, 2005, 2010) [39, 40], the
European Commission [41], and the Agency for Toxic
Substances and Disease Registry [42]. In 2010, the 73rd
JECFA established a provisional tolerable monthly in-
take (PTMI) of 25 μg/month/kg body weight (bw)
based on the findings of previous epidemiological
studies [40]. The European Food Safety Authority rec-
ommended a considerably lower tolerable weekly in-
take of 2.5 μg/week/kg bw (i.e., nearly 10.7 μg/
month/kg bw) based on an analysis of the relationship
between UCd levels and tubular proteinuria [43]. The
Scientific Committee on Toxicity, Ecotoxicity and the
Environment of EC reported that adverse health effects
may occur even at a lower level of 0.5 μg/g cr [44]. Re-
cently, several guidance values for Cd exposure have
become available, such as bio-monitoring equivalents
(2 μg/g cr) [45] and human bio-monitoring values (1.0 μg/
L for adults; 0.5 μg/L for children/adolescents) [46]. These
values were significantly lower than the reference level
of 5.0 μg/g cr for Cd-induced kidney dysfunction rec-
ommended by the WHO [29] and MOHC [47]. In the
present study, the estimated threshold values for Cd-
induced renal dysfunction were within the range of
1.00 μg/g cr to 3.66 μg/g cr, which provides additional
scientific support for identifying a lower biological limit
for Cd exposure and a provisional tolerable monthly
intake (PTMI).
This study covers a wide range of ages and Cd ex-
posure levels in both men and women. Furthermore,
when considering the larger sample population size
than that of previous studies [18–21], we believe that
this study improved the accuracy of the BMD of UCd
for renal dysfunction in the Chinese population. How-
ever, this study has limitations that should be consid-
ered in future studies. The results of Japanese studies
showed that the prevalence of Uβ2-MG is increased
with increasing age in both sexes. The obtained
BMDL gradually decreased with increasing age, which
indicated that the margin between the threshold level
and average excretion level of urinary Cd was small
in the older population in Japan. Therefore, it is im-
portant to evaluate the threshold level of Cd exposure
in the general Chinese population, while accounting
for an age effect to prevent Cd’s toxic effects. Fur-
thermore, there are 56 ethnic groups from more than
30 provinces, municipalities and autonomous regions
in China. Large differences in the ethnic group, life-
style, and diet and health history of the study popula-
tion may also be important factors related to Cd-
induced adverse health effects. Further studies are
needed to reach a conclusion.
Conclusions
The BMD value of UCd for Uβ2-MG was related to the
participants’ geographic region and gender. The effect
of the participants’ geographic region on the BMD esti-
mate may be partially attributable to the large differ-
ences in Cd exposure level, ethnic group, lifestyle and
diet of the sample population in these study areas. The
overall BMDLs of UCd for Uβ2-MG with an excess risk
of 10 % in this large sample survey of 6103 subjects
was be 2.00 μg/g cr in males and 1.69 μg/g cr in
females, which were significantly lower than the refer-
ence level for Cd-related kidney dysfunction suggested
by the WHO. These findings provide additional scien-
tific support for reconsidering the threshold exposure
value and PTMI for Cd to protect people from Cd-
induced adverse health effects.
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